Sachs Jessica
Chief Medical Officer
Sachs Jessica has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 30, 2025.
On the most recent filing, Sachs Jessica is listed as Chief Medical Officer at Cogent Biosciences, Inc. Inside the rolling window, Sachs Jessica reported no open-market purchases and 1 open-market sale totaling $3.2M in COGT.
Companies traded
Other insiders at COGT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sachs Jessica made?
Sachs Jessica has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Sachs Jessica trade?
Sachs Jessica has filed SEC Form 4 disclosures for 1 company, including COGT.
When was Sachs Jessica's most recent SEC Form 4 filing?
Sachs Jessica's most recent SEC Form 4 filing on Tracefour is dated Dec 30, 2025.
What is Sachs Jessica's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sachs Jessica is listed as Chief Medical Officer.
What is Sachs Jessica's total buy and sell value in the current window?
Inside the rolling retention window, Sachs Jessica bought $0 and sold $3.2M based on SEC Form 4 filings.
What was Sachs Jessica's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 82,642 COGT shares on 2025-12-26, worth $3.2M, per SEC Form 4 filings.